表紙
市場調查報告書
商品編碼
1071396

泌尿道感染治療市場:規模,全球市場的預測(2022年∼2027年),產業趨勢,佔有率,成長,洞察,COVID-19影響,企業分析

Urinary Tract Infection Treatment Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis

出版日期: | 出版商: Renub Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球泌尿道感染治療的市場規模,2021年是99億6,000萬美金。該市場,預計2021年∼2027年之間以2.26%的年複合成長率擴大,2027年達到113億9,000萬美元。

泌尿道感染的盛行率上升,和為了檢驗、治療泌尿道感染到醫院回數增加,促進泌尿道感染治療市場成長。此外,治療泌尿道感染的抗生素的需求高漲和學名藥增加,也讓該市場前進。

本報告提供全球泌尿道感染治療市場相關調查,市場概要,以及各類型,各疾病類型,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 成長促進因素
  • 課題

第5章 全球泌尿道感染治療市場

第6章 市場佔有率-全球泌尿道感染治療市場

  • 各類型
  • 各疾病類型
  • 各地區

第7章 全球泌尿道感染治療市場,各類型

  • 奎諾酮
  • B-內醯胺頭孢菌素
  • Aminoglycosides
  • 青霉素
  • Azole
  • 其他

第8章 全球泌尿道感染治療市場,各疾病類型

  • 單純性泌尿道感染
  • 複雜性泌尿道感染
  • 其他

第9章 全球泌尿道感染治療市場,各地區

  • 美國
  • 歐洲
  • 亞太地區
  • 中東、非洲

第10章 波特的五力分析

  • 買方議價能力
  • 賣主談判力
  • 競爭的程度
  • 新加入業者的威脅
  • 替代品的威脅

第11章 企業分析

  • Novartis AG
  • Allergan
  • Bayer HealthCare Pharmaceuticals
  • Astrazeneca
  • GlaxoSmithKline PLC
  • Pfizer
  • Merck & Co., Inc
  • Bristol-Myers Squibb Company
目錄

Global Urinary Tract Infection Treatment Market is estimated to reach US$ 11.39 Billion in 2027. One of the most dominant clinical bacterial infections in pregnant women is a urinary tract infection. A urinary tract infection (UTI) affects the urethra, bladder, ureters, and kidneys, with most disorders affecting the lower urinary tract. Wherein, bacteria penetrate the urinary tract through the urethra and breed in the bladder, causing this type of infection.

Global Urinary Tract Infection Treatment Industry was US$ 9.96 Billion in 2021

The increased prevalence of urinary tract infections and the rise in the number of hospital visits for urinary tract infection testing and treatment predict that the urinary tract infection treatment market will grow significantly. Furthermore, the rising demand for antibiotics in the treatment of urinary tract infections and the increase in the number of generic players are also expected to propel the urinary tract infection treatment market forward.

COVID-19 Impact on the Urinary Tract Infection Treatment Industry:

The unusual increase in coronavirus-infected patients led to limited access to other primary care services was hampered, and non-COVID-19-related diagnoses such as urinary tract infection dropped significantly. As per our analysis, in 2020, the weekly rate of UTI diagnoses decreased somewhat, slowing the industry's expansion 2020. However, as the market is recovering, the rate of UTI diagnosis has increased over time; the market's growth has been favorably enhanced. The rising preponderance of diabetes and kidney stones and the introduction of combination medications are driving market expansion.

The Quinolones Segment Leads the Global Urinary Tract Infection Treatment Market:

By Types, Quinolones, B-lactam Cephalosporins, Aminoglycosides, Penicillin, and Azoles are among the categories included in our report. According to our estimates, the quinolones category will dominate the global urinary tract infection treatment market. Many doctors advise their patients to promptly take quinolones to get rid of their infection. Moreover, the quinolones sector is expected to increase at the fastest CAGR during the projected period. According to our analysis, Urinary Tract Infection Treatment Market Size set to grow by 2.26% during 2021-2027.

In the Urinary Tract Infection Treatment Industry, the Complicated UTIs Segment Holds a Major Share:

We have analyzed the market for uncomplicated and complicated UTIs based on disease type. According to our research, the urinary tract infection therapy market is dominated by Complicated UTIs. Furthermore, due to the rise in drug-resistant bacteria and overuse of antibiotics, the prevalence of complicated UTIs is predicted to rise in the future. Most doctors prescribe quinolones to treat complex UTI situations. Cephalosporin is the second-most-prescribed antibiotic for complex UTIs.

Regional Realms in Urinary Tract Infection Treatment Industry:

Our research covers the regional markets for America, Europe, Asia Pacific, the Middle East, and Africa. During the study period, America and Europe held a significant market share in the global urinary tract infection treatment market, according to our analysis. However, developing regions such as Asia-Pacific and the Middle East and Africa (MEA) are growing the urinary tract infection treatment market due to rising government initiatives for healthcare spending and increased knowledge about urinary tract infection treatment.

Key Players:

Novartis AG, Allergan, Bayer HealthCare Pharmaceuticals, AstraZeneca, GlaxoSmithKline PLC, Pfizer, Merck & Co., Inc, and Bristol-Myers Squibb Company are amongst the leading competitors in the urinary tract infection treatment industry. Further, to drive their company portfolio across the worldwide market, these organizations employ various techniques, including innovative product releases and R&D.

Renub Research latest report "Urinary Tract Infection Treatment Market, Global Forecast By Type (Quinolones, B-lactam Cephalosporins, Aminoglycosides, Penicillin, Azoles and Others), Disease Type (Uncomplicated UTI, Complicated UTI and Others), Region (America, Europe, Asia Pacific and MEA), Companies (Novartis AG, Allergan, Bayer HealthCare Pharmaceuticals, AstraZeneca, GlaxoSmithKline PLC, Pfizer, Merck & Co., Inc, and Bristol-Myers Squibb Company)" provides a detailed analysis of Urinary Tract Infection Treatment Industry.

Type - Market has been covered from 6 viewpoints:

  • 1. Quinolones
  • 2. B-lactam Cephalosporins
  • 3. Aminoglycosides
  • 4. Penicillin
  • 5. Azoles
  • 6. Others

Disease Type - Market has been covered from 3 viewpoints:

  • 1. Uncomplicated UTI
  • 2. Complicated UTI
  • 3. Others

Region - Market has been covered from 4 viewpoints:

  • 1. America
  • 2. Europe
  • 3. Asia Pacific
  • 4. Middle East & Africa

Company Insights:

  • Company Profile
  • Recent Developments
  • Revenue

Companies Covered:

  • 1. Novartis AG
  • 2. Allergan
  • 3. Bayer HealthCare Pharmaceuticals
  • 4. Astrazeneca
  • 5. GlaxoSmithKline PLC
  • 6. Pfizer
  • 7. Merck & Co., Inc
  • 8. Bristol-Myers Squibb Company

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Urinary Tract Infection Treatment Market

6. Market Share - Global Urinary Tract Infection Treatment Market

  • 6.1 By Type
  • 6.2 By Disease Type
  • 6.3 By Regions

7. Type - Global Urinary Tract Infection Treatment Market

  • 7.1 Quinolones
  • 7.2 B-lactam Cephalosporins
  • 7.3 Aminoglycosides
  • 7.4 Penicillin
  • 7.5 Azoles
  • 7.6 Others

8. Disease Type - Global Urinary Tract Infection Treatment Market

  • 8.1 Uncomplicated
  • 8.2 Complicated UTI
  • 8.3 Others

9. Regions- Global Urinary Tract Infection Treatment Market

  • 9.1 America
  • 9.2 Europe
  • 9.3 Asia Pacific
  • 9.4 MEA

10. Porters Five Forces

  • 10.1 Bargaining Power of Buyers
  • 10.2 Bargaining Power of Suppliers
  • 10.3 Degree of Competition
  • 10.4 Threat of New Entrants
  • 10.5 Threat of Substitutes

11. Company Analysis

  • 11.1 Novartis AG
    • 11.1.1 Company Profile
    • 11.1.2 Recent Developments
    • 11.1.3 Revenue
  • 11.2 Allergan
    • 11.2.1 Company Profile
    • 11.2.2 Recent Developments
    • 11.2.3 Revenue
  • 11.3 Bayer HealthCare Pharmaceuticals
    • 11.3.1 Company Profile
    • 11.3.2 Recent Developments
    • 11.3.3 Revenue
  • 11.4 Astrazeneca
    • 11.4.1 Company Profile
    • 11.4.2 Recent Developments
    • 11.4.3 Revenue
  • 11.5 GlaxoSmithKline PLC
    • 11.5.1 Company Profile
    • 11.5.2 Recent Developments
    • 11.5.3 Revenue
  • 11.6 Pfizer
    • 11.6.1 Company Profile
    • 11.6.2 Recent Developments
    • 11.6.3 Revenue
  • 11.7 Merck & Co., Inc
    • 11.7.1 Company Profile
    • 11.7.2 Recent Developments
    • 11.7.3 Revenue
  • 11.8 Bristol-Myers Squibb Company
    • 11.8.1 Company Profile
    • 11.8.2 Recent Developments
    • 11.8.3 Revenue

List of Figures

  • Figure-01: Global - Urinary Tract Infection Treatment Market (Billion US$), 2018 - 2021
  • Figure-02: Global - Forecast for Urinary Tract Infection Treatment Market (Billion US$), 2022 - 2027
  • Figure-03: Type - Quinolones Market (Million US$), 2017 - 2021
  • Figure-04: Type - Forecast for Quinolones Market (Million US$), 2022 - 2027
  • Figure-05: Type - B-lactam Cephalosporins Market (Million US$), 2017 - 2021
  • Figure-06: Type - Forecast for B-lactam Cephalosporins Market (Million US$), 2022 - 2027
  • Figure-07: Type - Aminoglycosides Market (Million US$), 2017 - 2021
  • Figure-08: Type - Forecast for Aminoglycosides Market (Million US$), 2022 - 2027
  • Figure-09: Type - Penicillin Market (Million US$), 2017 - 2021
  • Figure-10: Type - Forecast for Penicillin Market (Million US$), 2022 - 2027
  • Figure-11: Type - Azoles Market (Million US$), 2017 - 2021
  • Figure-12: Type - Forecast for Azoles Market (Million US$), 2022 - 2027
  • Figure-13: Type - Others Market (Million US$), 2017 - 2021
  • Figure-14: Type - Forecast for Others Market (Million US$), 2022 - 2027
  • Figure-15: Disease Type - Uncomplicated Market (Million US$), 2017 - 2021
  • Figure-16: Disease Type - Forecast for Uncomplicated Market (Million US$), 2022 - 2027
  • Figure-17: Disease Type - Complicated UTI Market (Million US$), 2017 - 2021
  • Figure-18: Disease Type - Forecast for Complicated UTI Market (Million US$), 2022 - 2027
  • Figure-19: Disease Type - Others Market (Million US$), 2017 - 2021
  • Figure-20: Disease Type - Forecast for Others Market (Million US$), 2022 - 2027
  • Figure-21: America - Urinary Tract Infection Treatment Market (Million US$), 2017 - 2021
  • Figure-22: America - Forecast for Urinary Tract Infection Treatment Market (Million US$), 2022 - 2027
  • Figure-23: Europe - Urinary Tract Infection Treatment Market (Million US$), 2017 - 2021
  • Figure-24: Europe - Forecast for Urinary Tract Infection Treatment Market (Million US$), 2022 - 2027
  • Figure-25: Asia Pacific - Urinary Tract Infection Treatment Market (Million US$), 2017 - 2021
  • Figure-26: Asia Pacific - Forecast for Urinary Tract Infection Treatment Market (Million US$), 2022 - 2027
  • Figure-27: Middle-East & Africa - Urinary Tract Infection Treatment Market (Million US$), 2017 - 2021
  • Figure-28: Middle-East & Africa - Forecast for Urinary Tract Infection Treatment Market (Million US$), 2022 - 2027
  • Figure-29: Novartis AG - Global Revenue (Million US$), 2017 - 2021
  • Figure-30: Novartis AG - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-31: Allergan - Global Revenue (Million US$), 2017 - 2021
  • Figure-32: Allergan - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-33: Bayer HealthCare Pharmaceuticals - Global Revenue (Million US$), 2017 - 2021
  • Figure-34: Bayer HealthCare Pharmaceuticals - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-35: Astrazeneca - Global Revenue (Million US$), 2017 - 2021
  • Figure-36: Astrazeneca - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-37: GlaxoSmithKline PLC - Global Revenue (Million US$), 2017 - 2021
  • Figure-38: GlaxoSmithKline PLC - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-39: Pfizer - Global Revenue (Million US$), 2017 - 2021
  • Figure-40: Pfizer - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-41: Merck & Co., Inc - Global Revenue (Million US$), 2017 - 2021
  • Figure-42: Merck & Co., Inc - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-43: Bristol-Myers Squibb Company - Global Revenue (Million US$), 2017 - 2021
  • Figure-44: Bristol-Myers Squibb Company - Forecast for Global Revenue (Million US$), 2022 - 2027

List of Tables

  • Table-01: Global - Urinary Tract Infection Treatment Market Share by Type (Percent), 2017 - 2021
  • Table-02: Global - Forecast for Urinary Tract Infection Treatment Market Share by Type (Percent), 2022 - 2027
  • Table-03: Global - Urinary Tract Infection Treatment Market Share by Disease Type (Percent), 2018 - 2021
  • Table-04: Global - Forecast for Urinary Tract Infection Treatment Market Share by Disease Type (Percent), 2022 - 2027
  • Table-05: Global - Urinary Tract Infection Treatment Market Share by Region (Percent), 2017 - 2021
  • Table-06: Global - Forecast for Urinary Tract Infection Treatment Market Share by Region (Percent), 2022 - 2027